Cyrus J. Lawrence’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,293
| Closed | -$1.63M | – | 140 |
|
|
2024
Q4 | $1.63M | Sell |
2,293
-15
| -0.6% | -$10.7K | 0.32% | 40 |
|
|
2024
Q3 | $2.43M | Hold |
2,308
| – | – | 0.48% | 39 |
|
|
2024
Q2 | $2.43M | Hold |
2,308
| – | – | 0.49% | 41 |
|
|
2024
Q1 | $2.22M | Buy |
+2,308
| New | +$2.22M | 0.49% | 41 |
|
|
2023
Q3 | $1.9M | Hold |
2,308
| – | – | 0.52% | 41 |
|
|
2023
Q2 | $1.66K | Hold |
2,308
| – | – | 0.36% | 41 |
|
|
2023
Q1 | $1.9M | Hold |
2,308
| – | – | 0.55% | 40 |
|
|
2022
Q4 | $1.67M | Hold |
2,308
| – | – | 0.5% | 40 |
|
|
2022
Q3 | $1.59M | Hold |
2,308
| – | – | 0.31% | 42 |
|
|
2022
Q2 | $1.36M | Buy |
2,308
+3
| +0.1% | +$1.77K | 0.39% | 43 |
|
|
2022
Q1 | $1.61M | Buy |
+2,305
| New | +$1.61M | 0.37% | 44 |
|